SMAD7 and cancer: TGF-β signaling is pivotal in liver injuries leading to fibrosis [13], and expression of the negative regulator of TGF-β signaling, Smad7, can modulate liver injury, fibrosis and also cancer development in (for instance) hepatocytes [7,9,10].